ClearPoint Neuro Dividend
Dividend criteria checks 0/6
ClearPoint Neuro does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.82 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Oct 01ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company
Aug 06Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?
Jul 19Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
May 28Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation
May 27US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results
May 13ClearPoint Neuro partners with D&K Engineering
May 10ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Path To Profitability
Apr 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CLPT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CLPT's dividend payments have been increasing.
Dividend Yield vs Market
ClearPoint Neuro Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (CLPT) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Medical Equipment) | 1.8% |
Analyst forecast in 3 Years (CLPT) | n/a |
Notable Dividend: Unable to evaluate CLPT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CLPT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CLPT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CLPT has not reported any payouts.